Trademark: 85583401
Word
BIAL
Status
Dead
Status Code
710
Status Date
Friday, October 9, 2020
Serial Number
85583401
Registration Number
4490162
Registration Date
Tuesday, March 4, 2014
Mark Type
5000
Filing Date
Thursday, March 29, 2012
Published for Opposition
Tuesday, March 19, 2013
Cancellation Date
Friday, October 9, 2020

Trademark Owner History
BIAL-Portela & Ca., S.A. - Original Registrant

Classifications
5 Pharmaceutical preparations for the treatment of cardiovascular diseases, urological disorders, gastrointestinal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and respiratory diseases, fungal disorders; pharmaceutical preparations, namely, anti-inflammatory analgesics; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, tissue and skin repair preparations; pharmaceutical preparations, namely, decongestants and anti-histamines; pharmaceutical preparations for the treatment of pains, cough, fever, angina, otorhinolaryngological diseases, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; anaesthetics; analgesics; frostbite salve for pharmaceutical purposes; hemorrhoid treatment preparations; pharmaceutical preparations for the treatment of headaches; medicines for alleviating constipation; contraceptive preparations; radiological contrast substances for medical purposes; diagnostic preparations for medical purposes; pharmaceuticals for the treatment of pain, fever, angina, otorhinolaryngological diseases, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; pharmaceutical preparations for the treatment of diabetes, cancer; pharmaceutical preparations for the prevention and treatment of cancer, carcinomas and sarcomas; pharmaceutical preparations for the prevention and treatment of tumours of any description; pharmaceutical preparations, namely, platelet stimulating factors; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, bipolar disorder, neuropathic pain, migraine, generalized anxiety disorder, social phobia, diabetic neuropathies, panic disorder, postoperative pain, back pain, fibromyalgia, and postherpetic neuralgia, post-traumatic stress disorder, Parkinson's disease, Alzheimers; pharmaceutical preparations for the treatment of psychiatric diseases, namely, schizophrenia, anxiety disorders, mood disorders, cognitive disorders, depression, mania; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system; pharmaceutical preparations for treatment of gout, namely, broncho-dilators and anti-asthmatic preparations; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the peripheral nervous system, cardiovascular system, gastro-intestinal system; prescription pharmaceutical preparations and substances for use in pain control, anaesthesia, oncology; prescription pharmaceutical preparations and substances for the treatment and prevention of diabetes; pharmaceutical preparations and substances, namely, antibiotics, antivirals, antidiabetic preparations, nondepolarizing skeletal neuromuscular blocking agents, hemostatic agents, expectorants, anti-leukemia agents, anti-arrhythmics, dermatologicals and vasopressors; pharmaceutical preparations and substances for the treatment of cancer, HIV, obesity, and respiratory and urologic disorders and diseases; pharmaceutical preparations and substances for the treatment of acute ischemic stroke and traumatic brain injury (TBI); cerebral vasodilators; pharmaceutical preparations for the treatment of smooth muscle disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments or bone, tremors, namely, spasmodic smooth, striated or cardiac muscles, and pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical preparations for the treatment of muscle dystonias, nerve disorders, and spasmodic striated, smooth or cardiac muscles; pharmaceutical preparations for the treatment of cerebral palsy; pharmaceutical preparations, namely, muscle relaxants and anti-emetics, xanthine oxidase inhibitors; pharmaceutical preparations, namely, scabicides, anti-malarials
42 Pharmaceutical, medical and biological research and development in the field of human therapeutics; conducting of pre-clinical and clinical test research in the pharmaceutical and medical fields; scientific research and development in the field of human medicine
Color is not claimed as a feature of the mark.
The mark consists of the stylized letters "BIAL".

Trademark Events
Oct 9, 2020
Cancelled Sec. 8 (6-Yr)
Mar 4, 2019
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jan 15, 2015
Teas Change Of Correspondence Received
Mar 4, 2014
Registered-Principal Register
Jan 28, 2014
Paper Received
Jan 28, 2014
Ttab Release Case To Trademarks
Jan 28, 2014
Opposition Terminated No. 999999
Jan 28, 2014
Opposition Dismissed No. 999999
Jul 16, 2013
Opposition Instituted No. 999999
Apr 16, 2013
Extension Of Time To Oppose Received
Mar 19, 2013
Official Gazette Publication Confirmation E-Mailed
Mar 19, 2013
Published For Opposition
Feb 27, 2013
Notification Of Notice Of Publication E-Mailed
Feb 11, 2013
Law Office Publication Review Completed
Feb 11, 2013
Assigned To Lie
Jan 31, 2013
Approved For Pub - Principal Register
Jan 11, 2013
Teas/Email Correspondence Entered
Jan 11, 2013
Correspondence Received In Law Office
Jan 11, 2013
Teas Response To Office Action Received
Jul 11, 2012
Notification Of Non-Final Action E-Mailed
Jul 11, 2012
Non-Final Action E-Mailed
Jul 11, 2012
Non-Final Action Written
Jul 10, 2012
Assigned To Examiner
Apr 4, 2012
New Application Office Supplied Data Entered In Tram
Apr 2, 2012
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24